Catheter Precision
VTAK
12 hedge funds and large institutions have $103K invested in Catheter Precision in 2026 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
33% more funds holding
Funds holding: 9 → 12 (+3)
0.22% more ownership
Funds ownership: 4.1% → 4.32% (+0.22%)
18% less capital invested
Capital invested by funds: $125K → $103K (-$22.2K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$80.8K |
| 2 |
VF
Virtu Financial
New York
|
+$22.8K |
| 3 |
Jane Street
New York
|
+$19.3K |
| 4 |
HF
HRT Financial
New York
|
+$19.1K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$873 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$36.6K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$23.4K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1.32K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$544 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Geode Capital Management
Boston,
Massachusetts
| $48.1K | +$80.8K | +47,659 | New |
|
|
VF
2
Virtu Financial
New York
| $14K | +$22.8K | +13,472 | New |
|
|
3
Millennium Management
New York
| $13.3K | -$36.6K | -21,584 | -62% |
|
|
4
Jane Street
New York
| $11.5K | +$19.3K | +11,379 | New |
|
|
HF
5
HRT Financial
New York
| $11K | +$19.1K | +11,276 | New |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $3.93K | +$873 | +515 | +15% |
|
|
7
UBS Group
Zurich,
Switzerland
| $767 | -$1.32K | -779 | -51% |
|
|
AF
8
Allworth Financial
Folsom,
California
| $303 | +$508 | +300 | New |
|
|
PUI
9
Purpose Unlimited Inc
Toronto,
| $13 | – | – | – |
|
|
HI
10
Harbour Investments
Madison,
Wisconsin
| $8 | – | – | – |
|
|
SS
11
SBI Securities
Tokyo,
Japan
| $5 | – | – | – |
|
12
Citigroup
New York
| $1 | +$2 | +1 | New |
|
|
13
Citadel Advisors
Miami,
Florida
| – | -$23.4K | -12,771 | Closed |
|
|
14
Bank of America
Charlotte,
North Carolina
| – | -$544 | -297 | Closed |
|
VTAK Hedge Fund Activity: Q1 2026 in Review
12 of the 8,127 institutional investors tracked by Wall St. Rank reported a position in Catheter Precision (VTAK) for Q1 2026, worth a combined $103K — down 18% from $125K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new VTAK positions and 2 closed out — a net gain of 4 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $80.8K. The largest seller was Millennium Management, cutting an estimated $36.6K.
- 12 institutional investors held Catheter Precision (VTAK) as of Q1 2026, up from 9 in Q4 2025.
- Funds reported $103K of Catheter Precision stock for Q1 2026, down 18% quarter-over-quarter.
- 6 funds opened new Catheter Precision positions in Q1 2026 and 2 closed out, a net change of +4 holders.
- The largest Catheter Precision buyer in Q1 2026 was Geode Capital Management, an estimated $80.8K added.
- The largest Catheter Precision seller in Q1 2026 was Millennium Management, an estimated $36.6K sold.
Based on aggregated 13F filings for Q1 2026.